Quantification of prostate movements during radiotherapy;Quantification des mouvements prostatiques lors de l'irradiation prostatique

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 381-387

  Artignan, X ^a   Rastkhah, M ^a   Balosso, J ^a   Fourneret, P ^b   Gilliot, O ^c   Bolla, M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER DE CHAMBÉRY   (France)

^c CENTRE JEAN PERRIN   (France)

Author keywords

Prostate cancer; Prostate movements; Radiotherapy

Indexed keywords

ANATOMICAL VARIATION; ARTICLE; BLADDER FILLING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; MALE; MALE GENITAL SYSTEM; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; TREATMENT PLANNING; ENVIRONMENTAL MONITORING; MOVEMENT (PHYSIOLOGY); PATHOPHYSIOLOGY; PENIS; PROSTATE TUMOR; RADIOGRAPHY; REVIEW;

ENVIRONMENTAL MONITORING; HUMANS; MALE; MOVEMENT; PENIS; PROSTATE; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750470342     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.08.003     Document Type: Article

References (39)

1. Alasti H., Petric M.P., Catton C.N., and Warde P.R. Portal imaging for evaluation of daily on-line set up errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 869-884
2. Beard C.J., Kijewski P.K., Bussiere M.R., Gehnan R., Gladstone D., Schaffer K., et al. Analysis of prostate and seminal vesicle motion: Implications for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 34 (1996) 451-458
3. Dawson L.A., Litzenberg D.W., Brock K.K., et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 48 2 (2000) 319-323
4. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., Van Herk M., Shetty A., Sharpe M.B., et al. Prostate gland motion assessed with Cine-MRI. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 406-417
5. Gilhuijs K.G., El-Gayed A.A., van Herk M., and Vijlbrief R.E. An algorithm for automatic analysis of portal images: clinical evaluation for prostate treatments. Radiother. Oncol. 29 (1993) 261-268
6. Hang E., Dong L., Chandra A., et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 53 2 (2002) 261-268
7. Hanks G.E. Conformal radiotherapy for prostate cancer. Ann. Med. 32 (2000) 57-63
8. Hua C., Lovelock D.M., Mageras G.S., Katz M.S., Mechalakos J., Lief E.P., et al. Development of a semi-automatic alignment tool for accelerated localization of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 811-824
9. Husband J.E., Padhani A.R., MacVicar A.D., and Revell P. Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin. Radiol. 53 (1998) 673-681
10. Khoo V.S., Bedford J.L., Padhani A.R., Husband J., and Deamaley D.P. Prostate and rectal deformation assessed using cine magnetic resonance imaging (MRI) during a course of radical prostate radiotherapy. Radiother. Oncol. 64 suppl. 1 (2002) 285 (abstr)
11. Kitamura K., Shirato H., Seppenwoolde Y., Onimaru R., Oda M., Fujita K., et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1117-1123
12. Koper P.C., Stroom J.C., van Putten W.L., Korevaar G.A., Heijmen B.J., Wijnmaalen A., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomised study. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 727-734
13. Kupelian P.A., Mohan D.S., Lyons J., Klein E.A., and Reddy C.A. Higher than standard radiation doses with or without androgen deprivation in the treatment of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 46 (2000) 567-574
14. Little D.J., Dong L., Levy L.B., Chandra A., and Kuban D.A. Use of portal images and BAT ultrasonography to measure set up error and organ motion for prostate IMRT: Implications for treatment margins. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 1218-1224
15. Lyons J.A., Kupelian P.A., Mohan D.S., Reddy C.A., and Klein E.A. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 55 (2000) 85-90
16. Mah D., Freedman G., Milestone B., Hanlon A., Palacio E., Richardson T., et al. Measurement of intrafractional prostate motion using magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 568-575
17. Malone S., Crook J.M., Kendal W.S., et al. Respiratory-induced prostate motion quantification and characterization. Int J Radiat Oncol Biol Phys 48 1 (2000) 105-109
18. Mechalakos J.G., Mageras G.S., Zelefsky M.J., Lyass O., van Herk M., Kooy H.M., et al. Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy. Radiother. Oncol. 62 (2002) 261-265
19. Melian E., Kutcher G., Leibel S., Zelefski M., Balwin B., and Fuks Z. Variation in prostate position: quantification and implications for three-dimensional conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 27 Suppl. (1993) 137 (Abstr.)
20. Nederveen A.J., van der Heide U.A., Dehnad H., van Moorselaar R.J., Hofman P., and Lagendijk J.J. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 206-214
21. Padhani A.R., Khoo V.S., Suckling J., Husband J.E., Leach M.O., and Dearnaley D.P. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int. J. Radiat. Oncol. Biol. Phys. 44 (1999) 525-533
22. Pollack A., Zagars G.K., Smith L.G., Lee J.J., von Eschenbach A.C., Antolak J.A., et al. Preliminary results of a randomised radiotherapy dose-escalation study comparing 70 with 78 Gy for prostate cancer. J. Clin. Oncol. 18 (2000) 3904-3911
23. Pouliot J., Aubin M., Langen K.M., Liu Y.M., Pickett B., Shinohara K., et al. (Non)-migration of radio-opaque markers used for on-line localization of the prostate with an electronic portal-imaging device. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 862-866
24. Sandler H.M., McLaughlin P.W., Ten Haken R.K., Addison H., Forman J., and Lichter A. Three-dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int. J. Radiat. Oncol. Biol. Phys. 33 (1995) 797-801
25. Schallenkamp J.M., Herman M.G., Kruse J.J., and Pisansky T.M. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 800-811
26. Serago C.F., Chungbin S.J., Buskirk S.J., Ezzel G.A., Collie A.C., Vora S.A., et al. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1130-1138
27. Shimizu S., Shirato H., Kitamura K., et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys 48 5 (2000) 1591-1597
28. Shirato H., Harada T., Harabayashi T., Hida K., Endo H., Kitamura K., et al. Feasibility of insertion/implantation of 2.0 mm diameter gold internal fiducial markers for precise set up and real time tumor tracking in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 240-247
29. Tait D.M., Nahum A.E., Rigby L., Chow M., Mayles W.P., Dearnaley D.P., et al. Conformal radiotherapy of the pelvis: assessment of acute toxicity. Radiother. Oncol. 29 (1993) 117-126
30. Teh B.S., McGary J.E., Dong L., Mai W.Y., Carpenter L.S., Lu H.H., et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?. Cancer J. 8 (2002) 476-483
31. Ten Haken R.K., Forman J.D., Heimburger D.K., Gerhardsson A., McShan D.L., Perez-Tamayo C., et al. Treatment planning issues related to prostate movement in response to differential filing of the rectum and bladder. Int. J. Radiat. Oncol. Biol. Phys. 20 (1991) 1317-1324
32. Tinger A., Michalski J.M., Cheng A., Low D.A., Zhu R., Bosch W.R., et al. A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 213-221
33. van Herk M., Bruce A., Kroes A.P., Shouman T., Touw A., and Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three-dimensional image registration. Int. J. Radiat. Oncol. Biol. Phys. 33 (1995) 1311-1320
34. Vigneault E., Pouliot J., Laverdiere J., Roy J., and Dorion M. Electronic portal imaging device detection of radio-opaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int. J. Radiat. Oncol. Biol. Phys. 37 (1997) 205-212
35. Wachter S., Gerstner N., Dorner D., Goldner G., Colotto A., Wambersie A., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 91-100
36. Wu J., Haycocks T., Alasti H., Ottewell G., Middlemiss N., Abdolell M., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother. Oncol. 61 (2001) 127-133
37. Zelefsky M.J., Cowen D., Fuks Z., Shike M., Burman C., Jackson A., et al. Long-term tolerance of high-dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85 (1999) 2460-2468
38. Zelefsky M.J., Crean D., Mageras G.S., Lyass O., Happersett L., Ling C.C., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT-scans during conformal radiotherapy. Radiother. Oncol. 50 (1999) 225-234
39. Zelefsky M.J., Leibel S.A., Kutcher G.J., Kelson S., Ling C.C., and Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J. Sci. Am. 1 (1995) 142